Order Article Reprints

Mota AH, Duarte N, Serra AT, Ferreira A, Bronze MR, Custódio L, Gaspar MM, Simões S, Rijo P, Ascensão L, et al. Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations. Pharmaceutics. 2020; 12(12):1181. https://doi.org/10.3390/pharmaceutics12121181

Mota, Ana Henriques, Noélia Duarte, Ana Teresa Serra, António Ferreira, Maria Rosário Bronze, Luísa Custódio, Maria Manuela Gaspar, Sandra Simões, Patrícia Rijo, Lia Ascensão, and et al. 2020. "Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations" Pharmaceutics 12, no. 12: 1181. https://doi.org/10.3390/pharmaceutics12121181

Mota, A. H., Duarte, N., Serra, A. T., Ferreira, A., Bronze, M. R., Custódio, L., Gaspar, M. M., Simões, S., Rijo, P., Ascensão, L., Faísca, P., Viana, A. S., Pinto, R., Kumar, P., Almeida, A. J., & Reis, C. P. (2020). Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations. Pharmaceutics, 12(12), 1181. https://doi.org/10.3390/pharmaceutics12121181